Fast Market Research recommends "Abbott Laboratories: Company Analysis" from Datamonitor, now available
Boston, MA -- (SBWIRE) -- 10/16/2012 -- This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
- Gain insight into Abbott's strategic outlook across the next 6 years
- Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source.
Strategic insight into the prospects for Abbott over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
View Full Report Details and Table of Contents
Reasons to Get this Report
- Benchmark Abbott's performance against key rivals in the prescription pharmaceutical sector
- Examine how the spun out pharmaceuticals company Abbvie will fare as a standalone unit
- Discover how Abbott has utilized M&A to become one of the world's largest multi-disciplinary healthcare companies
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review
- Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review
- IMPAX Laboratories, Inc. (IPXL) - Financial and Strategic SWOT Analysis Review
- Columbia Laboratories Inc. (CBRX) - Financial and Strategic SWOT Analysis Review
- Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review
- Discovery Laboratories, Inc. (DSCO) - Financial and Strategic SWOT Analysis Review
- Divi's Laboratories Limited (DIVISLAB) - Financial and Strategic SWOT Analysis Review
- Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review